All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Research Progress on Astragalus and its Active Ingredients in Treating Chronic Obstructive Pulmonary Disease

Author(s): A. Zhao, H. Wang*, Xiaojuan Wu, Zhichengruan, Q. Ma, Tingting Wang and Yanyan Luo
Department of Traditional Chinese Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, Gansu 730000, 1Northwest Normal University, Lanzhou, Gansu 730070, 2Department of Medicine, Gansu Hospital of Traditional Chinese Medicine, Lanzhou, Gansu 730050, China

Correspondence Address:
H. Wang, Department of Medicine, Gansu Hospital of Traditional Chinese Medicine, Lanzhou, Gansu 730050, China, E-mail: zhaoaijun0922@163.com


The persistent restriction of airflow is a hallmark of chronic obstructive pulmonary disease. It includes alterations in lung tissue, emphysema, inflammation of the airways, and chronic bronchitis. Globally, chronic obstructive pulmonary disease is one of the leading causes of disability and death. Chronic obstructive pulmonary disease is categorized as lung distension, asthma syndrome and cough in traditional Chinese medicine, where the herb, Astragalus has tonic qualities, to bolster the body and ward off sickness. Astragalus has polysaccharides and saponins that lower inflammation, boost immunity, and lessen oxidative stress against chronic obstructive pulmonary disease. In order to aid in the development of novel chronic obstructive pulmonary disease treatments, this review focuses on the components and processes of Astragalus.

Full-Text | PDF

 
 
Google scholar citation report
Citations : 69022

Indian Journal of Pharmaceutical Sciences received 69022 citations as per google scholar report